Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-17

Clinical Trial Update: Study to Evaluate QLS-101 Compared to Timolol Maleate Eye Drops in Subjects With High Eye Pressure (Glaucoma or Ocular Hypertension). [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing QLS-101 to Timolol Maleate Eye Drops in adults with high eye pressure due to primary open-angle glaucoma or ocular hypertension has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QLS-101
  • Timolol Maleate Eye Drops (Timolol)

Snippet

Sponsor: Qlaris Bio, Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED